FINWIRES · TerminalLIVE
FINWIRES

Duality Biotherapeutics Advances Shanghai STAR Market Listing Plan

By

Duality Biotherapeutics (HKG:9606) said the Shanghai Stock Exchange accepted the application materials for the proposed share issue and listing on the Science and Technology Innovation Board, according to a Friday Hong Kong bourse filing.

Shares of the biotechnology company were up over 3% in Monday's late-morning trade.

Related Articles